Leo Pharma Uk/Ie company information, Employees & Contact Information

Leo Pharma's slow response to app lapse scolded by UK marketing watchdog Fierce Pharma

LEO Pharma bets on AI to find the next skin-care breakthrough Computing UK

MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain Yahoo Finance

LEO Pharma Achieves Positive DELTA TEEN Trial Results with Anzupgo® (delgocitinib) Cream in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) BioSpace

Leo Pharma's growth hope receives approval in the UK medwatch.com

LEO Pharma’s Anzupgo cream granted MHRA approval to treat chronic hand eczema PMLiVE

MHRA backs LEO Pharma’s Anzupgo in CHE The Pharma Letter

Pf Awards 2025 winners announced Pf Media

FDA Accepts LEO Pharma’s Filing of Delgocitinib Cream New Drug Application for the Treatment of Chronic Hand Eczema National Eczema Association

UK marketing watchdog slams Theramex for 'wholly unacceptable' compliance failings Fierce Pharma

Fucidin tablets recalled over impurity concern thepharmacist.co.uk

LEO Pharma and ICON partner for clinical trial execution in dermatology Clinical Trials Arena

Delgocitinib approved to treat adult patients with moderate to severe chronic hand eczema GOV.UK

Top 10: Biggest Pharma companies in Europe Healthcare Digital

LEO Pharma to market Junshi's PD-1 inhibitor Loqtorzi in Europe FirstWord Pharma

The pharma stocks leading the race for new drugs Investors' Chronicle

Leading Leo Pharma employee slammed in UK for actions bringing discredit on pharma industry medwatch.com

LEO Pharma appoints new Interim Vice President and General Manager Pf Media

LEO Pharma, Allergy UK and CHE Taskforce survey reveals burden of chronic hand eczema PMLiVE

Leo loses appeal against UK's most serious drug marketing breach as it’s censured for 'extremely concerning matter' Fierce Pharma

LEO Pharma Presents New Late-Breaking Delgocitinib Cream Data For the Third Consecutive Year at AAD 2025 BioSpace

LEO Pharma continues global rollout of Anzupgo® (delgocitinib) cream with submission of New Drug Application in China BioSpace

LEO Pharma appoints new General Manager and Vice President Pf Media

New eczema meds from AbbVie, Pfizer and Leo Pharma score NICE backing Fierce Pharma

Leo Pharma appoints new general manager for UK and Ireland medwatch.com

LEO Pharma Presents Late-breaking Tralokinumab Data at EADV 2024 for Moderate-to-Severe Atopic Dermatitis (AD) in the Difficult-to-Treat Head and Neck Region BioSpace

LEO pharma gains EU rights to Junshi Biosciences’ PD-1 inhibitor toripalimab PMLiVE

European Commission Approves LEO Pharma’s Anzupgo® (delgocitinib) Cream for Adults with Moderate to Severe Chronic Hand Eczema (CHE) BioSpace

Leo Pharma gains FDA nod for eczema drug Adbry, but can it challenge Sanofi and Regeneron's formidable Dupixent? Fierce Pharma

NICE Draft Guidance Does Not Recommend Funding for Leo Pharma’s Anzupgo for Chronic Hand Eczema NAVLIN DAILY

LEO Pharma’s delgocitinib cream shows promise in phase 3 chronic hand eczema trials PMLiVE

How the pandemic has changed one pharma company Pf Media

Utility Therapeutics sold to global pharma player: "A dream come true" medwatch.com

Germany Becomes the First Country to Launch LEO Pharma’s Anzupgo® (delgocitinib) Cream BioSpace

Dr Amit Aggarwal Association of the British Pharmaceutical Industry (ABPI)

Leo Pharma finds new head of UK and Ireland markets medwatch.com

LEO Pharma's Adtralza approved by MHRA, EC for adolescent atopic dermatitis pharmaphorum

LEO launches chronic hand eczema drug in its first market pharmaphorum

Leo Pharma appoints divisional directors at UK business PMLiVE

LEO Pharma launches Enstilar®, the first fixed-combination foam spray for the treatment of plaque psoriasis Hospital Pharmacy Europe

MHRA authorises novel pre-filled pen injector European Pharmaceutical Review

European Dermatology Forum recommends Leo Pharma drug in line with other biologics medwatch.com

Leo Pharma to withdraw from a quarter of its markets medwatch.com

Practical treatment guidance for cancer-associated thrombosis – Managing the challenging patient: A consensus statement ScienceDirect.com

Picato® launched by LEO Pharma Hospital Pharmacy Europe

‘What’s next for patient advocacy?’ Leaders share lessons of Patient Partnership Index 2021 at free virtual event PharmaTimes

LEO Pharma appoints J&J’s Michael Hinchy PMLiVE

Psoriasis patients get NHS access to LEO Pharma’s Kyntheum PharmaTimes

Enstilar launches in the UK for patients with plaque psoriasis European Pharmaceutical Review

Layoff Tracker: Alector Nearly Halves Workforce Following Dementia Drug Phase III Failure BioSpace

LEO Pharma delivers 11% revenue growth (CER) in H1 and upgrades financial outlook for the year Via Ritzau

Research reveals the emotional and physical impact of chronic hand eczema Allergy UK | National Charity

European Commission backs LEO Pharma’s Kyntheum PMLiVE

Research to understand the impact of hand eczema in the UK Allergy UK | National Charity

LEO Pharma launches Enstilar®, a fixed-combination foam spray for the treatment of plaque psoriasis Hospital Healthcare Europe

Liisa Hurme and Mark Levick elected to LEO Pharma’s Board of Directors Via Ritzau

In conversation: Federico Fanti, Global Head of Commercial Operations, LEO Pharma Pf Media

Leo Pharma plans to share trial data from 2014 PMLiVE

Leo Pharma appoints Geraldine Murphy as UK and Ireland MD PMLiVE

LEO Pharma signs agreement to acquire Timber Pharmaceuticals Via Ritzau

Pf Awards 2020 Winners Announced Pf Media

Pf Awards 2019: Delivering excellence at Leo Pharma Pf Media

Globally known professor and dermatologist joins LEO Pharma Via Ritzau

Biopharma Leaders Advance the Future of Life Sciences at Veeva Commercial Summit Europe PR Newswire UK

Pf Awards 2021 Winners Announced Pf Media

Commercial innovation and the future of pharma Pf Media

LEO Pharma hands Bartle Bogle Hegarty global eczema awareness brief Mediashotz

Ex-GW Pharma bosses lead development of new CBD-based epilepsy drug Cannabis Health News

New Vice President at LEO for Ireland Irish Medical Times

Pf Awards 2022 Winners Announced Pf Media

Manisha Raja, Dermatology Account Manager at LEO Pharma and winner of the Secondary Care Specialist Pf Award, on what motivates her to succeed. Pf Media

Pf Magazine Pf Media

Suffer from psoriasis? Foam spray could help thousands living with PAINFUL skin condition Daily Express

Give Nothing to Psoriasis VCCP

LEO Pharma appoints Business Unit Director Irish Medical Times

Skin in the game: Leo Pharma The Irish Independent

Walsall signs up first UK patient to eczema trial Walsall Healthcare NHS Trust